[1] MURRAY C J L,ARAVKIN A Y,ZHENG P,et al.Global burden of 87 risk factors in 204 countries and territories,1990–2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1223-1249.
[2] PATEL A R,PATEL A R,SINGH S,et al.Global initiative for chronic obstructive lung disease:the changes made[J].Cureus,2019,11(6):e4985.
[3] JAIN S,SELF W H,WUNDERINK R G,et al.Community-acquired pneumoniar requiring hospitalization among U.S.adults[J].N Engl J Med, 2015,373(5):415–427.
[4] VOYNOW J A,RUBIN B K.Mucins,mucus,and sputum[J].Chest,2009,135(2):505-512.
[5] SYED Z A, ZHANG L, HAGEN K G TEN.In vivo models of mucin biosynthesis and function[J].Adv Drug Deliv Rev,2022,184:114182.
[6] LI J,YE Z.The potential role and regulatory mechanisms of MUC5AC in chronic obstructive pulmonary disease[J].Molecules,2020,25(19):4437.
[10] KNAUS W A,DRAPER E A,WAGNER D P,et al.APACHE Ⅱ:A severity of disease classification system[J].Crit Care Med,1985,13(10):818-829.
[11] LI Y,YAN C,GAN Z,et al.Prognostic values of SOFA score,qSOFA score,and LODS score for patients with sepsis[J].Ann Palliat Med,2020,9(3): 1037-1044.
[12] HALILOGLU M, BILGILI B, BILGINER H,et al.A new scoring system for early diagnosis of ventilator-associated pneumonia:LUPPIS[J]. Arch Med Sci,2020,16(5):1040-1048.
[13] VOS T,LIM S S,ABBAFATI C,et al.Global burden of 369 diseases and injuries in 204 countries and territories,1990–2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1204-1222.
[14] PHUA J,NGERNG W J,LIM T K.The impact of a delay in intensive care unit admission for community-acquired pneumonia[J].Eur Respir J,2010,36(4):826-833.
[16] GONG H,SUN B,CHEN Y,et al.The risk factors of children acquiring refractory mycoplasma pneumoniae pneumonia:a meta-analysis[J].Medicine,2021,100(11):e24894.
[17] RIDLEY,THORNTON D J.Mucins:the frontline defence of the lung [J].Biochem Soc Trans,2018,46(5):1099-1106.
[18] SYMMES B A,STEFANSKI A L,MAGIN C M,et al.Role of mucins in lung homeostasis:regulated expression and biosynthesis in health and disease [J].Biochem Soc Trans,2018,46(3):707-719.
[19] MIYA C,CUENO M E,SUZUKI R,et al.Porphyromonas gingivalis gingipains potentially affect MUC5AC gene expression and protein levels in respiratory epithelial cells[J].FEBS Open bio,2021,11(2):446-455.
[20] KATO T, ASAKURA T, EDWARDS C E,et al.Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease[J].Am J Respir Crit Care Med,2022,206(11):1336-1352.
[21] HENKE M O,RENNER A,HUBER R M,et al.MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions[J].Am J Respir Cell Mol Biol,2004,31(1):86-91.
[22] CARAMORI G,CASOLARI P,DI GREGORIO C,et al.MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients[J].Histopathology,2010,55(3):321-331.
[23] WU S,LI H,YU L,et al.IL-1β upregulates Muc5ac expression via NF-κB-induced HIF-1α in asthma[J].Immunol Lett,2017,192:20-26